Close Menu

NEW YORK – Thermo Fisher Scientific said on Thursday that it has signed a partnership agreement with the Terasaki Innovation Center for discovering and developing new diagnostic tools to manage transplant patients.

Under the agreement, Thermo Fisher will have first rights to new technologies developed by TIC for transplant medicine. Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.